Mark Routbort

1.0k total citations
9 papers, 196 citations indexed

About

Mark Routbort is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Mark Routbort has authored 9 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Mark Routbort's work include Viral gastroenteritis research and epidemiology (2 papers), Viral Infections and Immunology Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). Mark Routbort is often cited by papers focused on Viral gastroenteritis research and epidemiology (2 papers), Viral Infections and Immunology Research (2 papers) and Acute Myeloid Leukemia Research (2 papers). Mark Routbort collaborates with scholars based in United States, Brazil and France. Mark Routbort's co-authors include Raymond P. Roos, Bert L. Semler, Lori J. Rosenstein, L. Jeffrey Medeiros, Robert L. Wollmann, Hagop M. Kantarjian, Daniel Jones, Carlos E. Bueso‐Ramos, Weina Chen and Jiang Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Mark Routbort

9 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Routbort United States 6 85 62 59 48 43 9 196
Maria Carmen Martín Spain 9 48 0.6× 20 0.3× 10 0.2× 159 3.3× 8 0.2× 15 287
Eva‐Lotta Larsson‐Sciard France 10 74 0.9× 4 0.1× 61 1.0× 43 0.9× 3 0.1× 14 330
Kongwei Huang China 8 12 0.1× 118 1.9× 21 0.4× 118 2.5× 59 1.4× 20 276
Tomoka Nakamura United States 7 11 0.1× 35 0.6× 8 0.1× 191 4.0× 10 0.2× 14 291
Sophia H.Y. Liao Australia 10 23 0.3× 9 0.1× 22 0.4× 230 4.8× 11 0.3× 11 311
Mary T. Bausch-Jurken United States 8 10 0.1× 8 0.1× 7 0.1× 70 1.5× 11 0.3× 19 242
Zhongjun Shao China 9 77 0.9× 5 0.1× 4 0.1× 171 3.6× 5 0.1× 17 287
Aaron Dillow United States 5 20 0.2× 98 1.6× 7 0.1× 189 3.9× 13 0.3× 12 330
Marti Cabanes‐Creus Australia 10 33 0.4× 7 0.1× 22 0.4× 216 4.5× 10 0.2× 13 335
Eoin Leen United Kingdom 8 79 0.9× 2 0.0× 49 0.8× 95 2.0× 2 0.0× 13 250

Countries citing papers authored by Mark Routbort

Since Specialization
Citations

This map shows the geographic impact of Mark Routbort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Routbort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Routbort more than expected).

Fields of papers citing papers by Mark Routbort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Routbort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Routbort. The network helps show where Mark Routbort may publish in the future.

Co-authorship network of co-authors of Mark Routbort

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Routbort. A scholar is included among the top collaborators of Mark Routbort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Routbort. Mark Routbort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gupta, Sanjeev, Nitin Jain, Guilin Tang, et al.. (2020). A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment Implications. Journal of the National Comprehensive Cancer Network. 18(10). 1300–1304. 3 indexed citations
2.
Sarshekeh, Amir Mehrvarz, Jonathan M. Loree, Ganiraju C. Manyam, et al.. (2018). The characteristics of ARID1A mutations in colorectal cancer.. Journal of Clinical Oncology. 36(15_suppl). 3595–3595. 5 indexed citations
3.
Loghavi, Sanam, Guillermo Garcia‐Manero, Mark Routbort, et al.. (2018). Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations. The American Journal of Surgical Pathology. 42(6). 799–806. 28 indexed citations
4.
Loree, Jonathan M., Vijaykumar Holla, Michael J. Overman, et al.. (2017). Not all RAS mutations created equal: Functional and clinical characterization of 80 different KRAS and NRAS mutations.. Journal of Clinical Oncology. 35(15_suppl). 3589–3589. 8 indexed citations
5.
Stockman, David L., Jonathan L. Curry, Carlos A. Torres‐Cabala, et al.. (2015). Use of clinical next‐generation sequencing to identify melanomas harboring SMARCB1 mutations. Journal of Cutaneous Pathology. 42(5). 308–317. 11 indexed citations
6.
Zuo, Zhuang, Keyur P. Patel, Sapna P. Patel, et al.. (2013). Clinical characteristics of melanoma patients with non-V600E/K BRAF mutations.. Journal of Clinical Oncology. 31(15_suppl). e20036–e20036. 3 indexed citations
7.
Chen, Weina, Georgios Z. Rassidakis, Jiang Li, et al.. (2006). High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations (“cuplike” nuclei). Blood. 108(5). 1783–1784. 34 indexed citations
8.
Rosenstein, Lori J., et al.. (1990). Neurovirulence determinants of genetically engineered Theiler viruses.. Proceedings of the National Academy of Sciences. 87(11). 4125–4129. 64 indexed citations
9.
Roos, Raymond P., et al.. (1989). Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. Journal of Virology. 63(10). 4469–4473. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Carmen Martín Breakdown of academic impact, for papers by Eva‐Lotta Larsson‐Sciard Breakdown of academic impact, for papers by Kongwei Huang Breakdown of academic impact, for papers by Tomoka Nakamura Breakdown of academic impact, for papers by Sophia H.Y. Liao Breakdown of academic impact, for papers by Mary T. Bausch-Jurken Breakdown of academic impact, for papers by Zhongjun Shao Breakdown of academic impact, for papers by Aaron Dillow Breakdown of academic impact, for papers by Marti Cabanes‐Creus Breakdown of academic impact, for papers by Eoin Leen
Rankless by CCL
2026